1-9 of 9
George Weiner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas

Clinical Trials & Observations
Thomas E. Witzig, Hui Tang, Ivana N. M. Micallef, Stephen M. Ansell, Brian K. Link, David J. Inwards, Luis F. Porrata, Patrick B. Johnston, Joseph P. Colgan, Svetomir N. Markovic, Grzegorz S. Nowakowski, Carrie A. Thompson, Cristine Allmer, Matthew J. Maurer, Mamta Gupta, George Weiner, Ray Hohl, Paul J. Kurtin, Husheng Ding, David Loegering, Paula Schneider, Kevin Peterson, Thomas M. Habermann, Scott H. Kaufmann
Journal: Blood
Blood (2011) 118 (18): 4882–4889.
https://doi.org/10.1182/blood-2011-02-334904
Published: 2011
Journal Articles

A Phase II Study of the Farnesyltransferase Inhibitor Tipifarnib Demonstrates Anti-Tumor Activity In Patients with Relapsed and Refractory Lymphomas

Thomas E. Witzig, MD, Tang Hui, PhD, Ivana N Micallef, MD, Stephen M. Ansell, MD, PhD, Brian Link, David James Inwards, MD, Luis Porrata, MD, Patrick B Johnston, MD, PhD, Joseph Colgan, Svetomir Markovic, MD, PhD, Grzegorz S. Nowakowski, MD, Carrie A Thompson, MD, Cristine Allmer, Matthew J Maurer, George Weiner, MD, Raymond J. Hohl, MD, PhD, Paul Kurtin, MD, Husheng Ding, PhD, Loegering A David, MD, Paula A Schneider, Kevin L Peterson, Thomas M. Habermann, MD, Scott H. Kaufmann, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 287.
https://doi.org/10.1182/blood.V116.21.287.287
Published: 2010
Journal Articles

CLL Cells From Subjects Treated with Rituximab and Alemtuzumab Can Lose Target Antigen and Develop Resistance to Mab-Mediated Complement Dependent Cytotoxicity

Ronald P Taylor, PhD, Clive S. Zent, MD, Paul V Beum, PhD, Margaret A Lindorfer, PhD, George Weiner, MD
Journal: Blood
Blood (2010) 116 (21): 3585.
https://doi.org/10.1182/blood.V116.21.3585.3585
Published: 2010
Journal Articles

Induction of a CTL-Like Phenotype In B-CLL Cells Stimulated with Interleukin 21 and CpG Oligodeoxynucleotides

Bernd Jahrsdoerfer, MD, Sue E Blackwell, Magdalena Hagn, MD, Verena Ebel, Thamara Beyer, Kai Sontheimer, Karen Dahlke, George Weiner, MD, Thomas Simmet, MD
Journal: Blood
Blood (2010) 116 (21): 3906.
https://doi.org/10.1182/blood.V116.21.3906.3906
Published: 2010
Journal Articles

Complement Enhances Foxp3+ T Regulatory Cell Induction by B Cell Lymphoma

Suresh Veeramani, DVM, PhD, Chris Dahle, MS, George Weiner, MD
Journal: Blood
Blood (2010) 116 (21): 5176.
https://doi.org/10.1182/blood.V116.21.5176.5176
Published: 2010
Journal Articles

Vitamin D Insufficiency and Prognosis In Chronic Lymphocytic Leukemia (CLL)

Tait Shanafelt, MD, Matthew Drake, Matthew Mauer, Cristine Allmer, Kari Rabe, Susan Slager, PhD, George Weiner, MD, Timothy Call, MD, Brian Link, Clive S. Zent, MD, Neil E. Kay, Curtis Hanson, Thomas E. Witzig, MD, James Cerhan, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2408.
https://doi.org/10.1182/blood.V116.21.2408.2408
Published: 2010
Journal Articles

Cancer Stem Cell Activity in Mantle Cell Lymphoma Is Inhibited by TLR9 Activation

Sarah Brennan, Bs, Brooke Meade, BA, Qiuju Wang, MA, George Weiner, MD, William Matsui, MD
Journal: Blood
Blood (2008) 112 (11): 884.
https://doi.org/10.1182/blood.V112.11.884.884
Published: 2008
Journal Articles

A Phase I Trial of CpG-7909, Rituximab Immunotherapy, and Y90 Zevalin Radioimmunotherapy for Patients (Pts) with Previously Treated CD20+ Non-Hodgkin Lymphoma (NHL).

Thomas E. Witzig, MD, Gregory A. Wiseman, MD, George Weiner, MD, Stephen M. Ansell, MD, PHD, Ivana Micallef, MD, Thomas M. Habermann, MD, Clive S. Zent, MD, David J. Inwards, MD, Tait Shanafelt, MD, Luis Porrata, MD, Matthew J. Maurer, MS, Cristine Allmer, Zuhair Ballas, MD
Journal: Blood
Blood (2007) 110 (11): 124.
https://doi.org/10.1182/blood.V110.11.124.124
Published: 2007
Journal Articles

Imaging of Peripheral Blood Mononuclear Cells (PBMC) Trafficking in Patients with Non-Hodgkin’s Lymphoma (NHL) Prior to and Following Therapy.

George Weiner, MD, Gregory Wiseman, MD, Thomas Witzig, MD, Brian Link, MD, James Wooldridge, MD, James Ponto, MD, Malik Juweid, MD
Journal: Blood
Blood (2005) 106 (11): 2823.
https://doi.org/10.1182/blood.V106.11.2823.2823
Published: 2005